Author

Tadafumi Hashimoto

National Center of Neurology and PsychiatryORCID 0000-0001-5442-4800Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Chihana Kabuta· 1 shared Hiromi Fujita· 1 shared Hisae KikuchiiD· 1 shared Hyeon‐Cheol LeeiD· 1 shared Ikuko Koyama‐HondaiD· 1 shared Katsunori Hase· 1 shared Keiji WadaiD· 1 shared Naruaki WatanabeiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Chihana Kabuta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyCell ReportsPeer-reviewedJun 1, 2025

The lysosomal membrane protein LAMP2B mediates microlipophagy to target obesity-related disorders

Ryohei Sakai, Shu Aizawa, Hyeon‐Cheol Lee…·Tomohiro Kabuta

This study identifies LAMP2B as a mediator of microlipophagy, showing its role in preventing obesity and related metabolic disorders through enhanced lipid hydrolysis.

17 citationstop 3%

mousemetabolomics

𝕏 PostBluesky

Molecular BiologyPLoS GeneticsPeer-reviewedAug 7, 2019

Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies

Sangeun Park, Sei-Kyoung Park, Naruaki Watanabe…·Susan Weiss Liebman

The paper shows that CREST toxicity in yeast and flies is reduced by PBP1/ATXN2 deletion, suggesting ATXN2 as a therapeutic target for ALS.

11 citations

yeastDrosophila

𝕏 PostBluesky